Načítá se...
Thyroid Cancer Radiotheragnostics: the case for activity adjusted (131)I therapy
Radiotheragnostics represents the systematic integration of diagnostic imaging and therapeutics using radionuclides targeting specific characteristics of tumor biology. Radioiodine ((131)I) is the classic radiotheragnostic agent used for the diagnosis and treatment of differentiated thyroid cancer (...
Uloženo v:
| Vydáno v: | Clin Transl Imaging |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430577/ https://ncbi.nlm.nih.gov/pubmed/30911535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40336-018-0291-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|